- Home
- RGLS vs FTK Comparison
RGLS vs FTK Comparison
Compare RGLS & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- FTK
- Stock Information
- Founded
- RGLS 2007
- FTK 1985
- Country
- RGLS United States
- FTK United States
- Employees
- RGLS N/A
- FTK N/A
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- FTK Major Chemicals
- Sector
- RGLS Health Care
- FTK Industrials
- Exchange
- RGLS Nasdaq
- FTK Nasdaq
- Market Cap
- RGLS 106.7M
- FTK 123.1M
- IPO Year
- RGLS 2012
- FTK N/A
- Fundamental
- Price
- RGLS $1.48
- FTK $4.80
- Analyst Decision
- RGLS Strong Buy
- FTK Strong Buy
- Analyst Count
- RGLS 6
- FTK 2
- Target Price
- RGLS $10.33
- FTK $6.75
- AVG Volume (30 Days)
- RGLS 263.0K
- FTK 68.8K
- Earning Date
- RGLS 11-07-2024
- FTK 11-04-2024
- Dividend Yield
- RGLS N/A
- FTK N/A
- EPS Growth
- RGLS N/A
- FTK N/A
- EPS
- RGLS N/A
- FTK 0.24
- Revenue
- RGLS N/A
- FTK $175,982,000.00
- Revenue This Year
- RGLS N/A
- FTK $0.33
- Revenue Next Year
- RGLS N/A
- FTK $11.86
- P/E Ratio
- RGLS N/A
- FTK $20.40
- Revenue Growth
- RGLS N/A
- FTK N/A
- 52 Week Low
- RGLS $1.08
- FTK $2.64
- 52 Week High
- RGLS $3.79
- FTK $5.61
- Technical
- Relative Strength Index (RSI)
- RGLS 44.54
- FTK 48.79
- Support Level
- RGLS $1.47
- FTK $4.70
- Resistance Level
- RGLS $1.65
- FTK $5.06
- Average True Range (ATR)
- RGLS 0.11
- FTK 0.21
- MACD
- RGLS -0.00
- FTK -0.03
- Stochastic Oscillator
- RGLS 15.79
- FTK 38.60
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven company focused on reducing the environmental impact of energy operations. Its Chemistry Technologies segment develops green specialty chemicals to enhance the profitability of hydrocarbon producers, catering to major players in the oil and gas industry. These chemicals improve operational efficiency and sustainability throughout the well life cycle. The Data Analytics segment provides real-time analytics for hydrocarbon streams, enabling users to optimize processes and increase profitability by reducing waste and reprocessing. Flotek's revenue primarily comes from its Chemistry segment, reflecting its commitment to providing solutions for environmental improvement in the energy sector.